Skip to content
2000
Volume 3, Issue 1
  • ISSN: 2666-8629
  • E-ISSN: 2666-8637

Abstract

L., a significant herbaceous species in Central Asia, has long been valued for its use in traditional medicine and as a source of textile fiber. This fast-growing plant has recently drawn increased attention because of its many applications. It is an abundant source of wood and cellulosic fibers and a true treasure of phytochemicals. This plant greatly interests the construction and pharmaceutical sectors because its metabolites have potent biological effects on human health. Its inner and outer stem tissues may be used to make concrete-like materials and bioplastics. This study aims to summarize the molecular and scientific knowledge of , including its pharmacognostic properties, pharmacological potential, phytochemical properties, and prospective future research fields.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cff/10.2174/0126668629285842240303141227
2024-03-20
2025-11-29

  • From This Site

    /content/journals/cff/10.2174/0126668629285842240303141227
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. SofoworaA. OgunbodedeE. OnayadeA. The role and place of medicinal plants in the strategies for disease prevention.Afr. J. Tradit. Complement. Altern. Med.2013105210229
     [Google Scholar]
  2. EvansW.C. Trease and Evans’ Pharmacognosy.16th edLondonWB Saunders Company Ltd2008
     [Google Scholar]
  3. SofoworaA. Medicinal plants and traditional medicine in Africa.3rd edIbadanSpectrum Books2008
     [Google Scholar]
  4. AndreC.M. HausmanJ.F. GuerrieroG. Cannabis sativa: The plant of the thousand and one molecules.Front Plant Sci201671910.3389/fpls.2016.00019 26870049
     [Google Scholar]
  5. ElSohlyM.A. RadwanM.M. GulW. ChandraS. GalalA. Phytochemistry of Cannabis sativa L.Prog. Chem. Org. Nat. Prod.201710313610.1007/978‑3‑319‑45541‑9_1 28120229
     [Google Scholar]
  6. BaldinoL. ScognamiglioM. ReverchonE. Supercritical fluid technologies applied to the extraction of compounds of industrial interest from Cannabis sativa L. and to their pharmaceutical formulations: A review.J. Supercrit. Fluids202016510496010.1016/j.supflu.2020.104960
     [Google Scholar]
  7. BrunettiP. PichiniS. PacificiR. BusardòF.P. del RioA. Herbal preparations of medical cannabis: A vademecum for prescribing doctors.Medicina202056523710.3390/medicina56050237 32429074
     [Google Scholar]
  8. LewisM.M. YangY. WasilewskiE. ClarkeH.A. KotraL.P. Chemical profiling of medical Cannabis extracts.ACS Omega2017296091610310.1021/acsomega.7b00996 30023762
     [Google Scholar]
  9. OdiekaA.E. ObuzorG.U. OyedejiO.O. GondweM. HosuY.S. OyedejiA.O. The medicinal natural products of Cannabis sativa Linn.: A review.Molecules2022275168910.3390/molecules27051689 35268790
     [Google Scholar]
  10. WHO World Health Organization2016Available from: https://www.who.int/publications/i/item/9789241510240
  11. UNODC2016Available from: https://www.unodc.org/e4j/en/crime-prevention-criminal-justice/module-12/index.html
  12. ModaresiF. TalachianK. The characteristics of clinical trials on cannabis and cannabinoids: a review of trials for therapeutic or drug development purposes.Pharmaceut. Med.202236638740010.1007/s40290‑022‑00447‑7 36357543
     [Google Scholar]
  13. Available from: https://sites.google.com/site/indiannamesofplants/via-species/c/cannabis-sativa (Assessed 23-02-2023).
  14. Marijuana Available from: http://www.flowersofindia.net/catalog/slides/Marijuana.html (Assessed 23-02-2023).
  15. Available from: https://www.google.com/search?q=cannabis+sativa+agriculture&rlz=1C1ONGR
  16. Available from: https://www.google.com/search?q=Traditional+use+of+cannabis+sativa+&rlz=1C1ONGR_enIN1021IN1021
  17. Available from: https://gobotany.nativeplanttrust.org/species/cannabis/sativa/ (Assessed 27-02-2023).
  18. RussoE.B. History of cannabis and its preparations in saga, science, and sobriquet.Chem. Biodivers.2007481614164810.1002/cbdv.200790144 17712811
     [Google Scholar]
  19. RajavashisthT.B. ShaheenM. NorrisK.C. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and Nutrition Examination Survey (NHANES) III.BMJ Open201221e00049410.1136/bmjopen‑2011‑000494 22368296
     [Google Scholar]
  20. CaoR. WangJ. ZhangW. Is Marijuana beneficial for prevention and treatment of diabetes?Am. J. Biomed. Sci.2017920021010.5099/aj170400200
     [Google Scholar]
  21. LevendalR.A. FrostC.L. In vivo effects of Cannabis sativa L. extract on blood coagulation, fat and glucose metabolism in normal and streptozocin-induced diabetic rats.Afr. J. Tradit. Complement. Altern. Med.20063411210.4314/ajtcam.v3i4.31172
     [Google Scholar]
  22. RamerR. HinzB. New insights into antimetastatic and antiangiogenic effects of cannabinoids.Int. Rev. Cell Mol. Biol.20153144311610.1016/bs.ircmb.2014.10.005 25619715
     [Google Scholar]
  23. MacHado RochaF.C. StéfanoS.C. De Cássia HaiekR. Rosa OliveiraL.M.Q. Da SilveiraD.X. Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: Systematic review and meta-analysis.Eur. J. Cancer Care200817543144310.1111/j.1365‑2354.2008.00917.x 18625004
     [Google Scholar]
  24. AlexanderA. SmithP.F. RosengrenR.J. Cannabinoids in the treatment of cancer.Cancer Lett.2009285161210.1016/j.canlet.2009.04.005 19442435
     [Google Scholar]
  25. FreimuthN. RamerR. HinzB. Antitumorigenic effects of cannabinoids beyond apoptosis.J. Pharmacol. Exp. Ther.2010332233634410.1124/jpet.109.157735 19889794
     [Google Scholar]
  26. SevcíkJ. MasekK. Potential role of cannabinoids in Parkinson’s disease.Drugs Aging200016639139510.2165/00002512‑200016060‑00001 10939305
     [Google Scholar]
  27. HernandezF. ChandraS. The current state and potential direction of cannabis research.J. Complement. Integr. Med.201664448
     [Google Scholar]
  28. SharmaSR GuptaP KumarR SinghB Marijuana from poison to pillsA Review JIAFM2006281629
     [Google Scholar]
  29. TomidaI. PertweeR.G. Azuara-BlancoA. Cannabinoids and glaucoma.Br. J. Ophthalmol.200488570871310.1136/bjo.2003.032250 15090428
     [Google Scholar]
  30. SwiftW. GatesP. DillonP. Survey of Australians using cannabis for medical purposes.Harm Reduct. J.2005211810.1186/1477‑7517‑2‑18 16202145
     [Google Scholar]
  31. SelvarajahD. GandhiR. EmeryC.J. TesfayeS. Randomized placebo-controlled doubleblind clinical trial of cannabis based medicinal product (Sativex) in painful diabetic neuropathy.Diabetes Care201033112813010.2337/dc09‑1029 19808912
     [Google Scholar]
  32. DensonT.F. EarleywineM. Decreased depression in marijuana users.Addict. Behav.200631473874210.1016/j.addbeh.2005.05.052 15964704
     [Google Scholar]
  33. FukudaS. KohsakaH. TakayasuA. Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis.BMC Musculoskelet. Disord.201415127510.1186/1471‑2474‑15‑275 25115332
     [Google Scholar]
  34. BridgemanM.B. DanielT. AbaziaD.T. Medicinal cannabis: History, pharmacology, and implications for the acute care setting.P&T2017423180188
     [Google Scholar]
  35. MoistoS.A. GalizioM. ConnorsG.J. Drug Use and Abuse.3rd edNew YorkHarcourt Brace College Publishers1999
     [Google Scholar]
  36. MeiriE. JhangianiH. VredenburghJ.J. Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.Curr. Med. Res. Opin.200723353354310.1185/030079907X167525 17355735
     [Google Scholar]
  37. Alsasua del ValleA. Implication of cannabinoids in neurological diseases.Cell. Mol. Neurobiol.2006264-657758910.1007/s10571‑006‑9070‑8 16699878
     [Google Scholar]
  38. AyenigbaraG.O. Cannabis sativa: A plant with multiple utilities, misunderstood, and a victim of controversial hypocrisy.J. Emerg. Trends Educ. Res. Policy Stud.201455459
     [Google Scholar]
  39. TashkinD.P. Does marijuana pose risks for chronic airflow obstruction?Ann. Am. Thorac. Soc.201512223523610.1513/AnnalsATS.201412‑581ED 25706487
     [Google Scholar]
  40. FischerB. ImtiazS. RudzinskiK. RehmJ. Crude estimates of cannabis-attributable mortality and morbidity in Canada–implications for public health focused intervention priorities.J Public Health201638118318810.1093/pubmed/fdv005 25630540
     [Google Scholar]
  41. LaiH.M.X. SitharthanT. Exploration of the comorbidity of cannabis use disorders and mental health disorders among inpatients presenting to all hospitals in New South Wales, Australia.Am. J. Drug Alcohol Abuse201238656757410.3109/00952990.2012.694523 22746224
     [Google Scholar]
  42. SanchesR.F. MarquesJ.M.A. Cannabis e humor.Rev. Bras. Psiquiatr.201032217318010.1590/S1516‑44462010000200014 20658056
     [Google Scholar]
  43. BorgesG. BaggeC.L. OrozcoR. A literature review and meta-analyses of cannabis use and suicidality.J. Affect. Disord.2016195637410.1016/j.jad.2016.02.007 26872332
     [Google Scholar]
  44. du PlessisS.S. AgarwalA. SyriacA. Marijuana, phytocannabinoids, the endocannabinoid system, and male fertility.J. Assist. Reprod. Genet.201532111575158810.1007/s10815‑015‑0553‑8 26277482
     [Google Scholar]
  45. The classification of cannabis under the misuse of drugs act 1971, advisory council on the misuse of drugs.2002Available from: https://assets.publishing.service.gov.uk/media/5a7ac2d840f0b66a2fc029f0/cannabis-class-misuse-drugs-act.pdf
  46. HazekampA. SimonsR. Peltenburg-LoomanA. SengersM. van ZwedenR. VerpoorteR. Preparative isolation of cannabinoids from Cannabis sativa by centrifugal partition chromatography.J. Liq. Chromatogr. Relat. Technol.200427152421243910.1081/JLC‑200028170
     [Google Scholar]
  47. LeghissaA. HildenbrandZ.L. SchugK.A. A review of methods for the chemical characterization of cannabis natural products.J. Sep. Sci.201841139841510.1002/jssc.201701003 28986974
     [Google Scholar]
  48. CittiC. BraghiroliD. VandelliM.A. CannazzaG. Pharmaceutical and biomedical analysis of cannabinoids: A critical review.J. Pharm. Biomed. Anal.201814756557910.1016/j.jpba.2017.06.003 28641906
     [Google Scholar]
  49. De BackerB. DebrusB. LebrunP. Innovative development and validation of an HPLC/DAD method for the qualitative and quantitative determination of major cannabinoids in cannabis plant material.J. Chromatogr. B Analyt. Technol. Biomed. Life Sci.2009877324115412410.1016/j.jchromb.2009.11.004 19932642
     [Google Scholar]
  50. Aizpurua-OlaizolaO. SoydanerU. ÖztürkE. Evolution of the cannabinoid and Terpene content during the growth of Cannabis sativa plants from different Chemotypes.J. Nat. Prod.201679232433110.1021/acs.jnatprod.5b00949 26836472
     [Google Scholar]
  51. DallügeJ. BeensJ. BrinkmanU.A.T. Comprehensive two-dimensional gas chromatography: A powerful and versatile analytical tool.J. Chromatogr. A200310001-26910810.1016/S0021‑9673(03)00242‑5 12877167
     [Google Scholar]
  52. GrögerT. SchäfferM. PützM. Application of two-dimensional gas chromatography combined with pixel-based chemometric processing for the chemical profiling of illicit drug samples.J. Chromatogr. A20081200181610.1016/j.chroma.2008.05.028 18539290
     [Google Scholar]
  53. OmarJ. OlivaresM. AmigoJ.M. EtxebarriaN. Resolution of co-eluting compounds of Cannabis sativa in comprehensive two-dimensional gas chromatography/mass spectrometry detection with multivariate curve resolution-alternating least squares.Talanta201412127328010.1016/j.talanta.2013.12.044 24607138
     [Google Scholar]
  54. BeasleyE. FranceseS. BassindaleT. Detection and mapping of cannabinoids in single hair samples through rapid derivatization and matrix-assisted laser desorption ionization mass spectrometry.Anal. Chem.20168820103281033410.1021/acs.analchem.6b03551 27648476
     [Google Scholar]
  55. HazekampA. PeltenburgA. VerpoorteR. GiroudC. Chromatographic and spectroscopic data of cannabinoids from Cannabis sativa.J. Liq. Chromatogr. Relat. Technol.200528152361238210.1080/10826070500187558
     [Google Scholar]
  56. MutjeP. Full exploitation of Cannabis sativa as reinforcement/filler of thermoplastic composite materials.Compos A Appl Sci Manuf200738236977
     [Google Scholar]
  57. Pourseyed LazarjaniM. TorresS. HookerT. FowlieC. YoungO. SeyfoddinA. Methods for quantification of cannabinoids: A narrative review.Journal of Cannabis Research2020213510.1186/s42238‑020‑00040‑2 33526084
     [Google Scholar]
  58. ZuardiA.W. History of cannabis as a medicine: A review.Rev. Bras. Psiquiatr.200628215315710.1590/S1516‑44462006000200015 16810401
     [Google Scholar]
  59. MunroS. ThomasK.L. Abu-ShaarM. Molecular characterization of a peripheral receptor for cannabinoids.Nature19933656441616510.1038/365061a0 7689702
     [Google Scholar]
  60. DevaneW.A. HanušL. BreuerA. Isolation and structure of a brain constituent that binds to the cannabinoid receptor.Science199225850901946194910.1126/science.1470919 1470919
     [Google Scholar]
  61. StellaN. SchweitzerP. PiomelliD. A second endogenous cannabinoid that modulates long-term potentiation.Nature1997388664477377810.1038/42015 9285589
     [Google Scholar]
  62. SugiuraT. KishimotoS. OkaS. GokohM. Biochemistry, pharmacology and physiology of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand.Prog. Lipid Res.200645540544610.1016/j.plipres.2006.03.003 16678907
     [Google Scholar]
  63. PiomelliD. The molecular logic of endocannabinoid signalling.Nat. Rev. Neurosci.200341187388410.1038/nrn1247 14595399
     [Google Scholar]
  64. De PetrocellisL. Di MarzoV. An introduction to the endocannabinoid system: From the early to the latest concepts.Best Pract. Res. Clin. Endocrinol. Metab.200923111510.1016/j.beem.2008.10.013 19285257
     [Google Scholar]
  65. AbouchedidR. HoJ.H. HudsonS. Acute toxicity associated with use of 5F-derivations of synthetic cannabinoid receptor agonists with analytical confirmation.J. Med. Toxicol.201612439640110.1007/s13181‑016‑0571‑7 27456262
     [Google Scholar]
  66. HuestisM.A. HenningfieldJ.E. ConeE.J. Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana.J. Anal. Toxicol.199216527628210.1093/jat/16.5.276 1338215
     [Google Scholar]
  67. LembergerL. AxelrodJ. KopinI.J. Metabolism and disposition of delta-9-tetrahydrocannabinol in man.Pharmacol. Rev.1971234371380 4943951
     [Google Scholar]
  68. GoulléJ.P. SaussereauE. LacroixC. (Delta-9-tetrahydrocannabinol pharmacokinetics).Ann. Pharm. Fr.200866423224410.1016/j.pharma.2008.07.006 18847571
     [Google Scholar]
  69. VandevenneM. VandenbusscheH. VerstraeteA. Detection time of drugs of abuse in urine.Acta Clin. Belg.200055632333310.1080/17843286.2000.11754319 11484423
     [Google Scholar]
  70. HuestisM.A. Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.Handb. Exp. Pharmacol.200516816865769010.1007/3‑540‑26573‑2_23 16596792
     [Google Scholar]
  71. GrotenhermenF. Pharmacokinetics and pharmacodynamics of cannabinoids.Clin. Pharmacokinet.200342432736010.2165/00003088‑200342040‑00003 12648025
     [Google Scholar]
  72. LindgrenJ.E. OhlssonA. AgurellS. Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis.Psychopharmacology1981743208212
     [Google Scholar]
  73. WallM. Perez-ReyesM. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man.J. Clin. Pharmacol.198121S1178S189S10.1002/j.1552‑4604.1981.tb02594.x 6271823
     [Google Scholar]
  74. Smith-KiellandA. SkuterudB. MørlandJ. Urinary excretion of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and cannabinoids in frequent and infrequent drug users.J. Anal. Toxicol.199923532333210.1093/jat/23.5.323 10488918
     [Google Scholar]
  75. HarveyD.J. Metabolism and pharmacokinetics of the cannabinoids. WatsonR.R. Biochemistry and physiology of substance abuse.Boca Raton, FLCRC Press1991279365
     [Google Scholar]
  76. HawksworthG. McArdleK. Metabolism and pharmacokinetics of cannabinoids. GuyG.W. WhittleB.A. RobsonP.J. The medicinal uses of cannabis and cannabinoids.LondonPharmaceutical Press2004205228
     [Google Scholar]
  77. HuestisM.A. Human cannabinoid pharmacokinetics.Chem. Biodivers.2007481770180410.1002/cbdv.200790152 17712819
     [Google Scholar]
  78. HuestisM.A. SmithM.L. Cannabinoid pharmacokinetics and disposition in alternative matrices. PertweeR.G. Handbook of cannabis.OxfordOxford University Press201429631610.1093/acprof:oso/9780199662685.003.0016
     [Google Scholar]
  79. DevinskyO. CilioM.R. CrossH. Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.Epilepsia201455679180210.1111/epi.12631 24854329
     [Google Scholar]
  80. Almogi-HazanO. OrR. Cannabis, the endocannabinoid system and immunity—the journey from the bedside to the bench and back.Int. J. Mol. Sci.20202112444810.3390/ijms21124448 32585801
     [Google Scholar]
  81. SalzetM. BretonC. BisognoT. Di MarzoV. Comparative biology of the endocannabinoid system.Eur. J. Biochem.2000267164917492710.1046/j.1432‑1327.2000.01550.x 10931174
     [Google Scholar]
  82. IngvardsenC.R. Brinch-PedersenH. Challenges and potentials of new breeding techniques in Cannabis sativa.Front Plant Sci202314115433210.3389/fpls.2023.1154332 37360738
     [Google Scholar]
/content/journals/cff/10.2174/0126668629285842240303141227
Loading
Phytopharmacological Update on Cannabis sativa (Ganja): A Mini Review
Curr Func Foods 3, E200324228176 (2025); https://doi.org/10.2174/0126668629285842240303141227
/content/journals/cff/10.2174/0126668629285842240303141227
/content/journals/cff/10.2174/0126668629285842240303141227
Loading

Data & Media loading...


  • Article Type:     Review Article
Keyword(s): bioplastics; Cannabis sativa; goldmine; pharmaceuticals; pharmacognostic; phytochemical

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test